Evidence map›Paper›PMID 27807147›Full record

ArticleJournal of clinical microbiology2017

Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.

Luis Furuya-Kanamori, Thomas V Riley, David L Paterson, Niki F Foster, Charlotte A Huber, Stacey Hong, Tiffany Harris-Brown, Jenny Robson, Archie C A Clements

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Spatiotemporal patterns of influenza in Western Australia.Public health in practice (Oxford, England) · 2025
    Article
  2. Genomic study of EuropeanMicrobial genomics · 2024
    Article
  3. Clinical microbiology reviews · 2024
    Review
  4. Using whole genome sequencing to characterizeAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  5. Biological characteristics associated with virulence inEmerging microbes & infections · 2020
    Article
  6. Review
  7. Gastroenterology report · 2018
    Review
  8. Review
  9. Article
  10. Article
  11. 2019 update of the WSES guidelines for management ofWorld journal of emergency surgery : WJES
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Luis Furuya-KanamoriResearch School of Population Health, The Australian National University, Canberra, ACT, Australia.
Thomas V RileyMicrobiology & Immunology, School of Pathology & Laboratory Medicine, The University of Western Australia, Nedlands, WA, Australia.
David L PatersonUQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia.
Niki F FosterMicrobiology & Immunology, School of Pathology & Laboratory Medicine, The University of Western Australia, Nedlands, WA, Australia.
Charlotte A HuberUQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia.
Stacey HongMicrobiology & Immunology, School of Pathology & Laboratory Medicine, The University of Western Australia, Nedlands, WA, Australia.
Tiffany Harris-BrownUQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia.
Jenny RobsonSullivan Nicolaides Pathology, Taringa, QLD, Australia.
Archie C A ClementsResearch School of Population Health, The Australian National University, Canberra, ACT, Australia director.rsph@anu.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridium difficile infection (CDI) is becoming less exclusively a health care-associated CDI (HA-CDI). The incidence of community-associated CDI (CA-CDI) has increased over the past few decades. It has been postulated that asymptomatic toxigenic C. difficile (TCD)-colonized patients may play a role in the transfer of C. difficile between the hospital setting and the community. Thus, to investigate the relatedness of C. difficile across the hospital and community settings, we compared the characteristics of symptomatic and asymptomatic host patients and the pathogens from these patients in these two settings over a 3-year period. Two studies were simultaneously conducted; the first study enrolled symptomatic CDI patients from two tertiary care hospitals and the community in two Australian states, while the second study enrolled asymptomatic TCD-colonized patients from the same tertiary care hospitals. A total of 324 patients (96 with HA-CDI, 152 with CA-CDI, and 76 colonized with TCD) were enrolled. The predominant C. difficile ribotypes isolated in the hospital setting corresponded with those isolated in the community, as it was found that for 79% of the C. difficile isolates from hospitals, an isolate with a matching ribotype was isolated in the community, suggesting that transmission between these two settings is occurring. The toxigenic C. difficile strains causing symptomatic infection were similar to those causing asymptomatic infection, and patients exposed to antimicrobials prior to admission were more likely to develop a symptomatic infection (odds ratio, 2.94; 95% confidence interval, 1.20 to 7.14). Our findings suggest that the development of CDI symptoms in a setting without establishment of hospital epidemics with binary toxin-producing C. difficile strains may be driven mainly by host susceptibility and exposure to antimicrobials, rather than by C. difficile strain characteristics.

Indexed as

RibotypingAdolescentAdultAgedAged, 80 and overAustraliaCarrier StateClostridioides difficileClostridium InfectionsCommunity-Acquired InfectionsCross InfectionEpidemiologic StudiesFemaleHospitalsHumansMaleasymptomaticClostridium difficilecommunity-acquired infectionshealth care-acquired infectionribotyping

Identifiers

PMID27807147
PMCPMC5228233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.